Universität zu Köln

Highly Crystalline and Semiconducting Imine-Based Two-Dimensional Polymers Enabled by Interfacial Synthesis (2020) Sahabudeen H, Qi H, Ballabio M, Polozij M, Olthof S, Shivhare R, Jing Y, et al. Journal article Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients (2020) Hack C, Häberle L, Brucker SY, Janni W, Volz B, Löhberg C, Hartkopf AD, et al. Journal article Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide) (2020) Chen W, Werner F, Illerhaus A, Knopp T, Voelker K, Potapenko T, Hofmann U, et al. Journal article Cultural taxonomies in the Paleolithic-Old questions, novel perspectives (2020) Riede F, Araujo AGM, Barton MC, Bergsvik KA, Groucutt HS, Hussain ST, Fernandez-Lopez De Pablo J, et al. Journal article Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib-results from a non-interventional multi-center study (2020) Westphalen CB, Kukiolka T, Garlipp B, Hahn L, Fuchs M, Malfertheiner P, Reiser M, et al. Journal article Last Neanderthal occupations at Central Iberia: the lithic industry of Jarama VI rock shelter (Valdesotos, Guadalajara, Spain) (2020) Ruiz MN, Jordá Pardo JF, Burow C, Kehl M, Pastoors A, Weniger GC, Wood R Journal article Role of Endogenous Regulators of Hem- And Lymphangiogenesis in Corneal Transplantation (2020) Clahsen T, Büttner C, Hatami N, Reis A, Cursiefen C Journal article, Review article A Randomized, Double-Blind, Phase III Trial of Neoadjuvant Chemotherapy (NACT) with atezolizumab/Placebo in Patients with Triple-Negative Breast Cancer (TNBC) Followed by Adjuvant Continuation of atezolizumab/Placebo (Gepardouze) (2020) Loibl S, Jackisch C, Seiler S, Rastogi P, Huober L, Denkert C, Schneeweiss A, et al. Conference contribution Serio - Side Effect Registry in Immuno-Oncology (2020) Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel ME, et al. Conference contribution Germline Mutation Status and Therapy Response in High-Risk Early-Stage Breast Cancer: a Secondary Analysis of the Geparocto Randomized Clinical Trial (NCT02125344) (2020) Pohl-Rescigno E, Hauke J, Rhiem K, Moebus V, Furlanetto J, Denkert C, Fasching P, et al. Conference contribution